Wednesday, May 03, 2023 Congratulations to Dr. Ali Hosni Abdalaty from Princess Margaret Cancer Centre (UHN) for his Ralph Meyer Phase III Program Young Investigator Award received at the CCTG Spring Meeting. The award is presented to a young investigator who worked the at CCTG Central Office, on a Phase III trial, or contributed significantly to the conduct of a Phase III trial at a member centre. "Thank you very much for the kind recognition. Looking forward to working more with CCTG." Dr Abdalaty is currently an assistant professor at University of Toronto Department of Radiation Oncology and radiation oncologist clinician-investigator at the Radiation Medicine Program - Princess Margaret Cancer Centre, and Clinician-Scientist of the Ontario Association of Radiation Oncologists. His research focus relates to his MSc and PhD work and is aligned with his training and clinical expertise in head and neck cancer and gastrointestinal malignancies. Dr Abdalaty global interest in clinical and experimental radiobiology with specific focus on the radiobiological principles that derive the tumour response and treatment-related toxicity. The overarching goal of his academic career and creative professional activity (CPA) is to improve the value of cancer care through developing optimal radiation therapeutic approach, implementing technology-driven research for radiation therapy innovation that contributes to clinical improvement, building and validation of outcome prediction models, and uncovering novel biomarkers that can be the basis of future clinical trials evaluating tailored new treatment de-escalation or intensification strategies.
